Abbott is voluntarily recalling millions of containers of its Similac-brand infant formula after beetles were found in its products and in one plant where the product is made.
In a move that is expected to cost the company US$100m, Abbott said yesterday (22 September) it recalled the products following an internal quality review, which detected the remote possibility of the presence of a small common beetle in the product.
Go deeper with GlobalData
“The United States Food and Drug Administration (FDA) has determined that while the formula containing these beetles poses no immediate health risk, there is a possibility that infants who consume formula containing the beetles or their larvae, could experience symptoms of gastrointestinal discomfort and refusal to eat as a result of small insect parts irritating the GI tract,” Abbott said.
The recall covers Similac in plastic containers and in eight-ounce, 12.4-ounce and 12.9-ounce cans that have been sold in the US, Puerto Rico, Guam and some countries in the Caribbean.
In a filing to the SEC, the company said the recall will cost it approximately US$100m in lost revenue, which will impact its third-quarter numbers.
See Also:
However, Abbott is maintaining its third-quarter ongoing earnings per share guidance of $1.03 to $1.05 and its full-year 2010 ongoing earnings per share guidance of $4.13 to 4.18.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe company’s share price remained largely unchanged at the close of the market on 22 September.
